December 11, 2017 by Geoff Walden and Chain Drug Review
Adam Fein, Amazon, Amazon and Pharmacy Retail, Amazon's U.S. Pharmacy Opportunity, Charles Rhyee, Cowen, Fung Global Retail & Technology, Pembroke Consulting
2017, Business, Issue 12-11-2017, Issues, Leading Headlines, News, Retail News

NEW YORK — While rumors of Amazon’s entry into pharmacy continue to swirl, some analysts are questioning just how significant the move would be. “Amazon’s U.S. Pharmacy Opportunity: Not Necessarily A Game Changer,” is the title of a report by Cowen. For its part, Fung Global Retail & Technology said the online retailer’s pursuit of
November 6, 2017 by Bill Schiffner
Adam Fein, Aetna, Amazon, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna deal, Humana, Larry Merlo, Mark Bertolini, MinuteClinic, OptumRx, Pembroke Consulting, UnitedHealth
2017, Issue 11-06-2017, Issues, News

WOONSOCKET, R.I. — At presstime The Wall Street Journal along with other news agencies reported that CVS Health will offer more than $200 per share, or about $66 billion, to purchase the health insurance giant Aetna Inc. Anonymous sources cited by WSJ originated the story about a potential CVS-Aetna deal. The possible transaction comes as
October 26, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Amazon entering the pharmacy market, Amazon's pharmacy market intentions, CBX, Drug Channels Institute, Greg Lipman, Jeffrey Woldt, pharmacy wholesale licenses, prescription drug business
CDR Blog

Amazon has quietly received approvals for pharmacy wholesale licenses from at least a dozen state pharmacy boards, the St. Louis Post-Dispatch reported Thursday. Those states are Alabama, Arizona, Connecticut, Idaho, Louisiana, Michigan, New Hampshire, New Jersey, Nevada, North Dakota, Oregon and Tennessee. Another pharmacy distribution license application is pending in Maine, the report said. Amazon
June 5, 2017 by Greg Jacobson and Chain Drug Review
Adam Fein, Amazon.com, Drug Channels Institute, Keith Anderson, Mark Lyons, pharmacy benefits, pharmacy industry, Premera Blue Cross, Profitero, retail pharmacy market
2017, Issue 06-05-2017, Issues, News

NEW YORK — The retail pharmacy market may soon face an unwelcome challenge from e-commerce giant Amazon.com Inc. According to a recent report by CNBC, the company has hired a number of people from the pharmacy industry and is conducting a search for a general manager to lead a team and create a strategy. The
May 23, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Drug Channels, Drug Channels Institute, online retailing
CDR Blog

Amazon’s success as a pioneer of online retailing is unquestioned, and it continues to be a disruptor to brick-and-mortar retailers (most recently, grocery retailers). But the e-tail giant’s alternatives in the pharmacy space — which CNBC reported it has targeted — aren’t so clear cut, according to pharmacy supply chain expert Adam Fein. “I would
April 24, 2017 by Chain Drug Review
Adam Fein, Affordable Care Act, American Health Care Act, Bob Kirby, CFRA, chain drug industry, chain drug stores, David Silverman, Drug Channels Institute, Fitch Ratings, Fred's, health insurance coverage, Joseph Agnese, Pembroke Consulting, Walgreens-Rite Aid merger
2017, Business, Featured Articles, Issue 04-24-2017, Issues, Leading Headlines, News, Retail News

NEW YORK — Entering the second quarter of 2017, the chain drug industry was awaiting answers to a couple of big, lingering questions. First, what will the chain drug landscape look like? A significant change in the field of players is likely in store pending antitrust clearance of Walgreens Boots Alliance Inc.’s (WBA’s) deal to
February 8, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Drug Channels Institute, pharmaceutical supply chain, pharmacy industry, specialty drugs, specialty pharmacy
CDR Blog

The rapid growth of the specialty pharmacy sector, fueled by high-priced specialty drugs, remains one of the leading story lines in the pharmacy industry. Compared with the retail pharmacy arena, the field of players in the specialty Rx market has yet to shake out. But pharmaceutical supply chain and economics expert Adam Fein, CEO of
November 11, 2016 by CDR Blog and Chain Drug Review
Adam Fein, CVS Caremark, CVS Health, CVS Pharmacy, Drug Channels, Drug Channels Institute, Maintenance Choice, OptumRx, Pembroke Consulting, pharmacy industry, Prime Therapeutics, Tricare, Walgreens Boots Alliance, WBA
CDR Blog

CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS
June 6, 2016 by Geoff Walden and Chain Drug Review
Adam Fein, Drug Channels Institute, generic drug sourcing, George Riedl, Mark Walchirk, McKesson, Pembroke Consulting, Walmart
2016, Issue 06-06-2016, Issues, News

BENTONVILLE, Ark. — Walmart has become the latest retailer to ally with a pharmaceutical distributor for generic drug sourcing. The mass merchandiser’s partnership with McKesson Corp. includes an expanded long-term distribution pact and will add scale and value for both companies, they said. The agreement positions Walmart and McKesson to compete with partnerships between Walgreens
May 17, 2016 by CDR Blog
Adam Fein, AmerisourceBergen, Cardinal Health, Drug Channels, Drug Channels Institute, McKesson, Pembroke Consultin, Rite Aid, Walgreens, Walmart
CDR Blog

The expanded distribution agreement between McKesson and Walmart not only brings McKesson a generic drug customer it had been pursuing, but it also “finalizes an intriguing industry channel alignment,” according to pharmacy supply chain expert Adam Fein, president of Pembroke Consulting. In a posting Tuesday on his Drug Channels blog, Fein noted that Walmart was
April 18, 2016 by Chain Drug Review
Adam Fein, chain drug stores, Drug Channels Institute, drug wholesalers, Joseph Agnese, Pembroke Consulting, pharmacy industry, pharmacy supply chain, retail pharmacy, S&P Capital IQ
2016, Business, Featured Articles, Issue 04-18-2016, Issues, Leading Headlines, News, Retail News

NEW YORK — Going forward, chain drug stores can bank on the same underlying trends that have fueled the retail pharmacy business in recent years. But the industry as they’ve known it won’t look quite the same. Retailer consolidation, changes in drug purchasing and the influx of specialty drugs are reshaping the competitive arena, industry
April 4, 2016 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, Drug Channels Institute, Larry Renfro, OptumRx, PBMs, Pembroke Consulting, pharmacy care, Walgreens, Walgreens Boots Alliance
2016, Issue 04-04-2016, Issues, News

DEERFIELD, Ill. — Walgreens is partnering with OptumRx to create a new pharmacy benefit to meet consumers’ changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings. OptumRx is UnitedHealth Group’s freestanding pharmacy care services business, managing more than a billion prescriptions annually. Through a
March 25, 2016 by CDR Blog
Adam Fein, AmerisourceBergen, Drug Channels Institute, OptumRx, Pembroke Consulting, Rite Aid, Walgreens Boots Alliance, WBA
CDR Blog

The presence of Walgreens Boots Alliance (WBA) across the pharmacy care sector continues to broaden and deepen. Over two days earlier this month, WBA unveiled an integrated pharmacy offering with PBM OptumRx and then announced that it’s boosting its equity stake in drug distributor AmerisourceBergen. The highlight of the offering with OptumRx is that members
February 19, 2016 by CDR Blog
Adam Fein, Drug Channels Institute, Pembroke Consultin, retail clinic, walk-in clinics
CDR Blog

Though the number of walk-in clinics in retail pharmacies has surged over the years, 2016 stands to see slow growth, says Adam Fein, CEO of the Drug Channels Institute. This week, Fein posted an overview of the retail clinic arena on his Drug Channels blog, including a chart listing the top players — CVS (MinuteClinic),